The Department of Health and Social Care (DHSC) has today (28/11/2025) confirmed the following list of price concessions for November 2025:
Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.
| Drug | Pack size | Price concession |
| Carbocisteine 250mg/5ml oral solution | 300 | £4.25 |
| Co-codamol 8mg/500mg capsules | 100 | £23.60 |
| Co-codamol 8mg/500mg capsules | 32 | £7.55 |
| Diclofenac sodium 50mg gastro-resistant tablets | 28 | £1.12 |
| Olanzapine 20mg orodispersible tablets sugar free | 28 | £6.96 |
| Oxybutynin 2.5mg tablets | 56 | £2.42 |
| Prucalopride 2mg tablets | 28 | £8.46 |
| Sulpiride 400mg tablets | 30 | £15.59 |
| Terbinafine 250mg tablets | 14 | £1.53 |
There are no prices that rolled over from the previous month.
Notes
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
Next Steps
Pharmacy team should continue to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on our website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, submit further price concession applications to DHSC. Any prices granted by DHSC, will only be agreed by Community Pharmacy England if they are supported by the reports received by our team.
Please subscribe to our mailing list to receive email updates on any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions)
The post November 2025 Price Concessions – 6th Update appeared first on Community Pharmacy England.